tiprankstipranks
Trending News
More News >
Advertisement
Advertisement
Novartis: Buy Rating Backed by Strong Rx Momentum, De-Risked Late-Stage Pipeline and Attractive Valuation
PremiumRatingsNovartis: Buy Rating Backed by Strong Rx Momentum, De-Risked Late-Stage Pipeline and Attractive Valuation
3d ago
White House releases details on Trump ‘Great Healthcare Plan’
Premium
The Fly
White House releases details on Trump ‘Great Healthcare Plan’
4d ago
Trump Trade: Trump administration moves to end pharma trade probe
Premium
The Fly
Trump Trade: Trump administration moves to end pharma trade probe
5d ago
Novartis upgraded to Equal Weight from Underweight at Barclays
PremiumThe FlyNovartis upgraded to Equal Weight from Underweight at Barclays
13d ago
Trump Weekly: Furniture tariffs delayed, drugmakers hike prices
Premium
The Fly
Trump Weekly: Furniture tariffs delayed, drugmakers hike prices
17d ago
Midday Fly By: Nvidia said to see strong H200 demand in China
Premium
The Fly
Midday Fly By: Nvidia said to see strong H200 demand in China
19d ago
Trump announces pacts with nine pharma companies to lower drug prices
PremiumThe FlyTrump announces pacts with nine pharma companies to lower drug prices
1M ago
Novartis reaches agreement on lowering drug prices in U.S.
Premium
The Fly
Novartis reaches agreement on lowering drug prices in U.S.
1M ago
Drugmakers set to make deals with Trump in exchange for incentives, WaPo reports
Premium
The Fly
Drugmakers set to make deals with Trump in exchange for incentives, WaPo reports
1M ago

Trending

Name
Price
Price Change
S&P 500
Dow Jones
Nasdaq 100